VivoSim Labs raises $4.0M through the sale of 4.70M shares and warrants to a healthcare-focused institutional investor.
VivoSim Labs (VIVS) has finalized a $4.0M private placement, selling 4.70M shares of common stock and warrants at a combined price of $0.85 per share. The transaction targets a single healthcare-focused institutional investor, marking a strategic capital infusion for the company.
The placement follows standard private offering terms, with proceeds likely earmarked for operational expansion or research and development. No prior public offering or consensus estimates were disclosed for comparison.
Details on immediate market reaction or trading volume changes were not provided in the release.